Eroxon Awarded “New Product of the Year” by Boots

Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the pharmaceutical company developing innovative sexual health products, announces that Eroxon® has won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023, following its UK launch earlier this year. The award is further recognition for Futura's breakthrough treatment for erectile dysfunction ("ED") as it provides an alternative treatment option for the 4.3 million men in the UK experiencing symptoms*.

James Barder, Chief Executive Officer of Futura said: "Winning the "New Product of the Year, Healthcare" award at this year's Boots Supplier Awards is great recognition for Eroxon® by one of Britain's most trusted brands. Eroxon® is a potential game changer for the 4.3 million men who suffer from ED in the UK and we are delighted to see it getting the recognition it deserves."

*Figures based on men reporting occasional and frequent difficulty getting or maintaining an erection, ref Kantar TNS Omnibus Survey Dec 2010 in a survey of 1,033 men. Stats are UK unless stated otherwise.